RC
Rowan E Chapman (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Natera, Inc. (NTRA). The largest single filing was $972K of NTRA (4,000 sh × $243.08, as filed), executed Dec 5 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.6M
shares × price, as filed
Last traded
Jun 16
Filed Jun 17
Median ADV $454.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
NTRARecent filings
NTRASALE
Natera, Inc.
View filing →
$643K2,964 sh × $216.78
Exec Jun 16
Filed Jun 17 · 5:30 PM ET NTRASALE Natera, Inc. View filing → $972K
4,000 sh × $243.08
Exec Dec 5 2025
Filed Dec 9 2025 · 5:30 PM ET NTRASALE Natera, Inc. View filing → $459K
2,750 sh × $166.99
Exec Aug 28 2025
Filed Sep 2 2025 · 5:30 PM ET NTRASALE Natera, Inc. View filing → $301K
1,767 sh × $170.24
Exec Dec 10 2024
Filed Dec 11 2024 · 5:30 PM ET